Pacira Biosciences reported a record revenue of $429.6 million last year, according to a Jan. 7 news release.
The full-year revenue was a 2 percent increase from $421 million in 2019, the release said. Total revenue includes net product sales of Exparel and Iovera.
Highlights from Pacira's fourth quarter include $125.3 million in net sales for Exparel and $22.4 million for Iovera, the release said. The company also saw $1.2 million in royalty revenue in 2020.
Read more details and figures from the fourth quarter here.